Showing results (181-190 of 285) with videos related to

Sort By:
Pageof 29
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2015
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis BMartine Lapalus, Cédric Laouenan, Ana-Carolina Cardoso, et al.
Digestive Diseases and Sciences|December 24, 2014
Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infectionMaria Buti, Naoky Tsai, Joerg Petersen, et al.
The New England Journal of Medicine|February 28, 2003
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis BStephanos J Hadziyannis, Nicolaos C Tassopoulos, E Jenny Heathcote, et al.
Hepatology Communications|January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2008
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2aPatrick Marcellin, George K K Lau, Stefan Zeuzem, et al.
Scientific Reports|October 13, 2016
MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and CKevin Appourchaux, Safi Dokmak, Matthieu Resche-Rigon, et al.
Journal of Hepatology|July 6, 2015
Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis BHenry Lik-Yuen Chan, Magdy Elkhashab, Huy Trinh, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
Cytokine--chemokine and apoptotic signatures in patients with hepatitis CManuela G Neuman, Jean-Pierre Benhamou, Patrick Marcellin, et al.
Pageof 29